Literature DB >> 2069461

Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome".

F W Holland1, P S Brown, B D Weintraub, R E Clark.   

Abstract

The purpose of this prospective study was to define the effect of cardiopulmonary bypass on the concentrations of thyroid hormones and metabolites. Blood samples were obtained from 14 patients preoperatively, at specific times throughout cardiopulmonary bypass, and serially to 24 hours postoperatively. Thyroid-stimulating hormone, thyroid-binding globulin, total thyroxine, triiodothyronine (T3), and reverse T3, an inactive metabolite of thyroxine, were measured by radioimmunoassay. Free T3 was assayed by equilibrium dialysis. Values of total T3 and free T3, the active hormone, were significantly depressed (75% and 50%, respectively) up to 24 hours after bypass (p less than 0.05). Reverse T3 demonstrated a greater than fourfold rise at 8 and 24 hours postoperatively (p less than 0.05). Thyroid-binding globulin was decreased at all sampling times (p less than 0.05). Thyroid-stimulating hormone, thyroxine, and free thyroxine levels remained within normal ranges at all sampling times. These results indicate that cardiopulmonary bypass simulates the "euthyroid sick syndrome" as seen in severely burned patients and critically ill patients, which is characterized by depression of T3 and free T3 concentrations with a concomitant increase in reverse T3 levels and normal concentrations of thyroid-stimulating hormone, thyroxine, and free thyroxine. The hemodynamic effects of primary hypothyroidism are well established. These data provide further support for investigational trials of intravenous administration of T3 in the prevention or treatment of low cardiac output syndrome after cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069461     DOI: 10.1016/0003-4975(91)91416-s

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  19 in total

Review 1.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

Review 2.  Thyroid hormone and heart failure.

Authors:  Ursula Maria Schmidt-Ott; Deborah Davis Ascheim
Journal:  Curr Heart Fail Rep       Date:  2006-09

3.  The non-thyroidal illness syndrome in acute coronary syndrome is associated with increased cardiac morbidity and mortality.

Authors:  J Adawiyah; A W Norasyikin; N H Mat; A S Shamsul; K Nor Azmi
Journal:  Heart Asia       Date:  2010-07-06

4.  Effect of triiodothyronine administration in experimental myocardial injury.

Authors:  R B Hsu; T S Huang; Y S Chen; S H Chu
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

5.  Detrimental effects of thyroid hormone analog DITPA in the mouse heart: increased mortality with in vivo acute myocardial ischemia-reperfusion.

Authors:  M A Hassan Talukder; Fuchun Yang; Yoshinori Nishijima; Chun-An Chen; Lin Xie; Shouvik D Mahamud; Anuradha Kalyanasundaram; John D Bonagura; Muthu Periasamy; Jay L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-03       Impact factor: 4.733

6.  Identifying infants at risk of marked thyroid suppression post-cardiopulmonary bypass.

Authors:  Kevin Plumpton; Nikolaus A Haas
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

Review 7.  New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

8.  Tri-iodothyronine supplement protects gut barrier in septic rats.

Authors:  Zhi-Li Yang; Lian-Yue Yang; Geng-Wen Huang; He-Li Liu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 9.  Rebuilding the post-infarcted myocardium by activating 'physiologic' hypertrophic signaling pathways: the thyroid hormone paradigm.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2008-09-05       Impact factor: 4.214

Review 10.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.